Literature DB >> 2521347

Transfusion induces blood donor-specific suppressor cells.

R L Quigley1, K J Wood, P J Morris.   

Abstract

Transfusion with blood from the organ donor before transplantation can prolong the survival of renal allografts in the rat. To determine if the beneficial effect of preoperative blood transfusion was due to the generation of donor-specific suppressor cells, in vivo and in vitro adoptive transfer experiments were performed. Lymphoid cells were harvested from transfused and untreated rats. These cells were then either (1) transferred to lightly irradiated (200 R) syngeneic hosts which were subsequently challenged with a kidney allograft (in vivo assay) or (2) titrated as regulator cells into naive unidirectional MLC such that the regulator and responder populations were syngeneic. In the LEW-RT1 to DA-RT1av1 strain combination, the adoptive transfer of thoracic duct lymph (TDL) or lymph node (LN) cells (5 x 10(7) to 7.5 x 10(7) cells) from DA animals transfused with LEW blood, 7 days previously into syngeneic (DA), lightly irradiated (200 R) hosts resulted in the indefinite survival of LEW kidney allografts. The phenomenon was blood donor-specific and dose-dependent. In contrast the adoptive transfer of spleen cells (10(7) to 10(8] from blood transfused hosts 7 days after transfusion had no effect on renal allograft survival. In vitro the addition of LN or TDL regulator cells, harvested from DA rats transfused with LEW blood, to a unidirectional MLC (DA responders, LEW stimulators) resulted in a significant depression of the proliferative response when compared with the proliferation of these same cells without the addition of these regulator cells or with the addition of LN or TDL regulator cells from a DA rat transfused with third party (PVG-RT1c) blood. The depression of the proliferative response observed in vitro, was blood donor specific. When LN or TDL regulator cells from a DA rat transfused with PVG-RT1c blood were added to a unidirectional MLC between DA responders and PVG stimulators, a significant depression in the proliferative response was observed. These in vitro findings were confirmed in two other strain combinations (LEW-PVG, and DA-PVG). Thus a single blood transfusion results in the induction of donor-specific suppressor cells detectable both in vivo and in vitro 7 days after transfusion in some but not all lymphoid compartments.

Entities:  

Mesh:

Year:  1989        PMID: 2521347

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  CD47 in xenograft rejection and tolerance induction.

Authors:  Yong-Guang Yang
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

2.  CD47 is required for suppression of allograft rejection by donor-specific transfusion.

Authors:  Hui Wang; Xiaojian Wu; Yuantao Wang; Per-Arne Oldenborg; Yong-Guang Yang
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

3.  Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis.

Authors:  A Bharat; F Barros; K Narayanan; B Borg; M Lisker-Melman; S Shenoy; J Lowell; J Crippin; W Chapman; T Mohanakumar
Journal:  Am J Transplant       Date:  2008-06       Impact factor: 8.086

4.  Activation of lymphocytes after platelet allotransfusion possessing only class I MHC product.

Authors:  E Pócsik; R Mihalik; E Gyódi; M Réti; K Pálóczi; G G Petrányi; M Benczúr
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 5.  Moving to tolerance: clinical application of T regulatory cells.

Authors:  Alicia N McMurchy; Andrew Bushell; Megan K Levings; Kathryn J Wood
Journal:  Semin Immunol       Date:  2011-05-28       Impact factor: 11.130

6.  Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts.

Authors:  Yuta Abe; Hidejiro Urakami; Dmitry Ostanin; Gazi Zibari; Tetsu Hayashida; Yuko Kitagawa; Matthew B Grisham
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.